Company: CERO
Filing Date: 2025-04-22
Form Type: 8-K
Source: 0001213900-25-033946
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-22
Form: 8-K
Item: Item 3.02
Chunk 1
---
 from its public offering of shares of common stock, pre-funded warrants
and warrants to purchase shares of common stock that closed on February 7, 2025 (the “February Offering”). As a result
of such capital raising activities and the proceeds of the Private Placement received on the First Closing Date, as well as successful
negotiations with certain service providers to reduce outstanding balances payable, the Company believes that it has stockholders’
equity of $2.5 million requirement as of the date of this filing and is awaiting a compliance determination from Nasdaq. Until Nasdaq
has reached a final determination that the Company has regained compliance with all of the applicable continued listing requirements,
there can be no assurances regarding the continued listing of the Company’s common stock and warrants on the Nasdaq Capital Market
and the Company could be subject to delisting.

Item 9.01 Financial Statements and Exhibits.